THANK YOU TO EVERYONE WHO MADE THE 2018 COURSE A SUCCESS!
This is the 33rd year of the course, “Medical and Surgical Aspects of Esophageal and Foregut Disorders: Pathophysiology and Treatment”. This year we are pleased to again bring together outstanding leaders in the field of Esophageal Disease as faculty and special guests. The faculty brings broad experience in benign and malignant esophageal disease from diverse locations throughout the United States and Europe to ensure a comprehensive, state-of-the-art yet balanced approach to the diagnosis and management of patients with esophageal and foregut disorders.
We are extremely pleased to announce that our special guest faculty this year is Dr. Joachim Labenz and Dr. John Reynolds.
John Reynolds is our special surgical guest and comes from Trinity School of Medicine in Dublin, Ireland. Professor Reynolds clinical interest is in diseases of the Esophagus and Stomach, while his research interest lies in four areas: 1) Pathogenesis of Barrett’s Esophagus, 2) Prediction of response and resistance to chemotherapy and radiation therapy, 3) obesity, altered metabolism, and cancer, and 4) malnutrition and peri-operative nutrition. He will be sharing his knowledge on the role of obesity in GERD and Barrett’s Esophagus along with concepts about neoadjuvant therapy for esophageal cancer.
Joachim Labenz is our special medical guest and comes from Diakone Klinikum in Siegen, Germany. He is a member of the Faculty of Medicine of the University of Duisburg-Essen. Professor Labenz is a globally recognized researcher and expert in Gastroenterology and Hepatology. He is widely known for his work evolving around GERD, and will be discussing the Pro-GERD data in relationship to CIM and Barrett’s Esophagus. Together they will provide unique insights into the GERD spectrum as well as Barrett’s and Cancer.
For those that have not been before, the course is specifically designed to have the feel and interaction of a small-group classroom environment where questions, comments and discussion are encouraged. The course is open to all physicians and allied health personnel with an interest in esophageal and foregut disorders and is particularly appreciated by gastroenterologists and gastrointestinal surgeons who focus on the diagnosis and treatment of patients with esophageal disorders, and for those who have or are interested in developing a swallowing center and function as a team to collaboratively approach esophageal problems. The lectures are detailed and supported by existing literature and on-going research to provide cutting-edge information that can be immediately applied to patient care. Each lecture is followed by ample time for often vigorous discussion and interaction between the faculty and attendees as areas of controversy are further explored and debated. Featured topics this year will include GERD Diagnostics, medical and surgical therapy for GERD, Barrett’s esophagus and esophageal cancer. We will discuss the “Spectrum of GERD” and debate whether therapy should depend on GERD stage. We will cover esophageal cancer staging, endoscopic therapy for early cancer and options including immunotherapy to treat patients with advanced cancer. In addition, the interactive audience response session that was initiated last year will continue this year with a session on the SuperBowl of Manometry–where participants will see typical, unusual, and rare abnormalities on motility tracings and have an opportunity to try to identify the abnormality and discuss the tracings in detail with experts in HRM. As in prior years there will be “hands-on” break-out sessions involving high resolution motility, esophageal pH and pH + impedance monitoring, stents, and novel diagnostic and therapeutic technologies. This portion of the course will expose the participants to each of these areas along with instruction, assistance and information exchange from the faculty. It promises to be a truly interesting, informative and enjoyable educational experience.
We hope you can join us on the beautiful Hawaiian Island of Maui this February!
New this year
We are introducing the DON AND TOM ATTENDEE. Our vision is that a fellow or young attending (within the first 2 years after fellowship) with plans for a career in esophageal disease be sponsored to attend the course. The plan would be to alternate each year between a gastroenterologist and a surgeon. Find out more information about how you can support a fellow or young attending by going to our Don & Tom Sponsored Attendee page.
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the American College of Surgeons and Foundation for Research and Education in Esophageal and Foregut Disease. The American College of Surgeons is accredited by the ACCME to provide continuing medical education for physicians.
AMA PRA Category 1 Credits™: The American College of Surgeons designates this live activity for a maximum of 29.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ABS MOC Program: This activity will also provide self-assessment credits towards Part 2 of the ABS MOC Program. In order to claim self-assessment credits toward Part 2 of the American Board of Surgery (ABS) Maintenance of Certification (MOC) Program, eligible learners must complete and pass (75% passing rate) a graded quiz. Please note that only ABS qualified surgeons are eligible for MOC credit.
Of the AMA PRA Category 1 Credits™ listed above, a maximum of 26.50 credits meet the requirements for Self-Assessment.
This activity is designed for physicians and allied health personnel with an interest in esophageal and foregut disorders and is particularly appreciated by gastroenterologists and gastrointestinal surgeons who focus on the diagnosis and treatment of patients with esophageal disorders. At the conclusion of this course, participants should be able to:
- Understand the normal function and pathophysiology of the esophageal body and sphincters and the appropriate use of esophageal function studies.
- Interpret esophageal diagnostic studies including high-resolution manometry, pH and impedance testing, and novel technologies including optical coherence tomography and endomicroscopy.
- Appropriately recommend intervention for paraesophageal hernias and understand the controversy regarding repair techniques and mesh use at the hiatus.
- Discuss the epidemiology and risk factors for GERD, Barrett’s esophagus and esophageal adenocarcinoma.
- Stage esophageal cancer and discuss the options and outcomes with endoscopic and surgical management for early stage esophageal cancer.
|Thursday, February 8|
|6:00 A.M.||Continental Breakfast / Introductions and Welcome||Dr. S DeMeester|
|Session 1: GERD DiagnosticsTotal 5.75|
|6:30 A.M.||Definition and Diagnosis of GERD1.00||Dr. Katz|
|7:30 A.M.||Definition and Diagnosis of GERD: Pathology Perspective1.00||Dr. Chandrasoma|
|8:30 A.M.||GERD in the Pediatric Patient0.75||Dr. Geiger|
|9:30 A.M.||Fundamentals of HRM and the Chicago Classification System0.50||Dr. Dunst|
|10:00 A.M.||Coffee Break and Case Discussions|
|10:30 A.M.||The Evolution and Value of Impedance pH Testing0.75||Dr. Castell|
|11:15 A.M.||Evaluation of the GERD patient for Antireflux Surgery1.00||Dr. S DeMeester|
|12:00 P.M.||Superbowl of Manometry0.75||Dr. Dunst|
|2:00-4:30 P.M.||* Simultaneous Certificate Courses:|
LINX: Magnetic Reflux Management System
Boston Scientific: Endoscopic Intervention with Stents and Clips
Pinnacle Biologics : PDT for Esophageal Disease
|4:30-5:30 P.M.||* Wrap-up and Refreshments||Plantation PreFunction & Lanai|
|* Additional registration fee|
|5:30 P.M.||WELCOME RECEPTION for All Attendees and immediate family guests||Makai Lawn|
|Friday, February 9|
|Session 2: GERD SpectrumTotal 6.00|
|6:00 A.M.||Continental Breakfast / Case Presentation: (LPR)0.50||Dr. DeMeester|
|6:30 A.M.||LPR: is it GERD or Something Else?1.00||Dr. DeVault|
|7:30 A.M.||Debate: Testing in Patients with Persistent Symptoms on PPI Therapy:0.75|
Imp-pH testing on PPI is best test
Bravo pH Testing Off Medications is Best Test
Dr. S DeMeester
|8:15 A.M.||The Role of Obesity and Inflammation in GERD and Barrett's Esophagus1.00||Dr. Reynolds|
|9:15 A.M.||GERD is a Progressive Disease: the Pro-GERD Data0.75||Dr. Labenz|
|10:15 A.M.||Coffee Break and Case Discussions|
|11:00 A.M.||Debate: Therapy Should Depend on GERD Stage and Include Endoscopic and Novel Devices1.00||PRO: Dr. Louie|
CON: Dr. Spechler
|12:00 P.M.||CIM, Barrett's and the Pro-GERD Data1.00||Dr. Labenz|
|2:00-4:30 P.M.||* Ablation Technologies Certificate Course:|
BarrX, Interscope EndoRotor
C2 Therapeutics: CryBalloon, TruFreeze Spray Cryotherapy
|4:30-5:30 P.M.||* Wrap-up and Refreshments||Hawaii Medicinal Garden|
|* Additional registration fee|
|Saturday, February 10|
|Session 3: GERD TherapyTotal 4.50|
|6:00 A.M.||Continental Breakfast / From Concept to Product: Device Development in the Current Healthcare Environment0.50||Dr. Geiger|
|6:30 A.M.||ProGERD Study: An Alternative Viewpoint1.00||Dr. Spechler|
|7:30 A.M.||Ignoring the GEJ at Endoscopy Puts Patients at Peril1.00||Dr. Labenz|
|8:30 A.M.||Interactive New Technology Sessions: Session I-7 (Sessions Will Be @ 30 Mins Each)|
Seven Simultaneous Sessions Will Be Presented:NO CME
|1. Mucosal Impedance: A New Testing Paradigm for Diagnostic Testing (Sandhill/Diversatek)||Plantation 2|
|2. Pharyngeal pH Monitoring (ResTech)||Plantation 1|
|3. Enhanced Esophageal Biopsy and Tissue Analysis (CDX)||Oahu Room|
|4.Controversies Around Mesh at the Hiatus (BARD/Davol)||Plantation 3|
|5. Comprehensive Esophageal Assessment of GERD Patients with Cellvizio (Mauna Kea)||Plantation 3|
|6. Endoscopic Esophageal Diagnostic and Therapeutic Tools (Boston Scientific)||Plantation 2|
|7. PDT for Esophageal Disease (Pinnacle Biologics)||Maui Room|
|10:30 A.M.||Coffee Break and Case Discussions|
|11:00 A.M.||Update on LINX: Is It Just for Early Disease and Small Hernias?0.75||Dr. Louie|
|11:45 A.M.||Debate: GERD Therapy Today: Too Little, Too Late?1.25||PRO: Dr. Peters|
CON: Dr. Katz
|Sunday, February 11 – FREE DAY|
|Monday, February 12|
|6:00 A.M.||Early Risers Video Session (LINX in Big Hernia)0.50||Dr. Louie|
|6:30 A.M.||Continental Breakfast / Case Presentation: (Barrett's)0.50||Dr. DeMeester|
|Session 4: Barrett's and Cancer (Session A)Total 4.25|
|7:00 A.M.||Are Goblet Cells Necessary for the Diagnosis of Barrett's Esophagus?0.75||Dr. Spechler|
|7:45 A.M.||Outcome of Antireflux Surgery for CIM and Barrett's Esophagus0.75||Dr. Katz|
|8:30 A.M.||Staging and Endoscopic Options for Esophageal Cancer0.75||Dr. Schnoll-Sussman|
|9:15 A.M.||Who Needs Neoadjuvant Therapy and What Therapy Should Be Used?1.00||Dr. Reynolds|
|10:15 A.M.||Coffee Break and Case Discussions|
|Session 5: Barrett's and Cancer (session B)Total 2.25|
|10:45 A.M.||Modern Chemotherapy Regimens for Esophageal Cancer0.75||Dr. Leidner|
|11:30 A.M.||Optimizing Neoadjuvant Therapy: MSK Experience0.75||Dr. Molena|
|12:15 P.M.||Can We Predict Response to Neoadjuvant Therapy?0.75||Dr. Reynolds|
|6:30 P.M.||COURSE DINNER||Aloha Garden Ballroom|
|Tuesday, February 13|
|6:00 A.M.||Early Risers Video Session (MIE Esophagectomy)0.50||Dr. Molena|
|6:30 A.M.||Continental Breakfast / Case Presentation (Cancer)0.50||Dr. Louie|
|Session 6: Esophageal TumorsTotal 3.25|
|7:00 A.M.||Immunotherapy for Esophageal Cancer0.75||Dr. Leidner|
|7:45 A.M.||Elements of a Good Operation for Esophageal Cancer0.75||Dr. S DeMeester|
|8:30 A.M.||GEJ Cancer: Is Limited Resection Appropriate?0.75||Dr. Molena|
|Session 7: Foregut PotpourriTotal 3.00|
|9:15 A.M.||Current Concepts in the Diagnosis and Management of EOE0.75||Dr. DeVault|
|10:00 A.M.||Coffee Break and Case Discussions|
|10:30 A.M.||Hereditary Gastrointestinal Cancer Syndromes That Impact the Upper GI Tract0.75||Dr. Schnoll-Sussman|
|11:15 A.M.||Endoscopic and Surgical Management of GIST Tumors0.75||Dr. Louie|
|12:00 P.M.||The Syndrome of Gastroparesis and Management Strategy0.75||Dr. Dunst|
Annual Course Supporters
The Foundation for Research and Education in Esophageal and Foregut Disease wishes to recognize and thank the following companies for their ongoing support through educational grants:
The Foundation for Research and Education in Esophageal and Foregut Disease wishes to recognize and thank the following companies for their marketing and exhibitor support:
- Boston Scientific
- Torax Medical Inc.
- Bard Davol Inc.
- W.L. Gore and Associates
- EndoRotor by Interscope, Inc.
- CDx Diagnostics
- Mauna Kea Technologies
- Pinnacle Biologics, Inc.
- EndoGastric Solutions
- Diversatek Healthcare
- C2 Therapeutics Inc.
- LSI Solutions Inc.
- CSA Medical/truFreeze